Clinical trial
Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After…
NCT00314756 · Wake Forest University, Other · Completed
Key facts
| NCT number | NCT00314756 |
|---|---|
| Title | Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage |
| Official title | Topical Imiquimod 5% Cream in the Treatment of Nodular Basal Cell Carcinoma After Initial Treatment With Curettage |
| Lead sponsor | Wake Forest University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Basal Cell Carcinoma |
| Intervention type | Drug |
| Interventions | imiquimod |
| Enrollment | 15 |
| Start date | Mar 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Apr 14, 2006 |
| Last update posted | Aug 22, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: